Stem Cell Medicine Ltd. (SCM), of Jerusalem, Ramot at Tel Aviv University Ltd., and Yeda Research and Development Co. Ltd. (YEDA), have entered into a license and research funding agreement. SCM will fund stem cell-based treatments for neuronal disease research at Tel Aviv University in cooperation with the Weizmann Institute of Science.